What happened
ClinicalTrials.gov registry update for Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
SourceClinicalTrials.govclinical updateBiotech
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Clinical/translation signal: Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Factual summary
Why it matters
Clinical trial registry updates are translation signals, not commercialization claims by themselves.
SourceClinicalTrials.govLimitations
ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.
SourceClinicalTrials.govLinked output
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumorsclinical trialPeople
No reviewed person relationship is attached to this event.
Organizations
Topics
No reviewed topic relationship is attached to this event.
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors (NCT01841736)
Timeline
- clinical updatePazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors